Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
11/11/2015 | 00:52 | The Motley Fool | Packer backs Crown Resorts Ltd with $200 million bet | ASX:DNA | Donaco International Ltd |
27/03/2009 | 16:13 | Dow Jones News | UPDATE: FDA 'Unclear' If Avastin Data Backs Expanded Approval | NYSE:DNA | Genentech Inc. (Delisted 3/27/09) |
27/03/2009 | 15:35 | Dow Jones News | FDA 'Unclear' If Genentech Drug Data Backs Expanded Approval | NYSE:DNA | Genentech Inc. (Delisted 3/27/09) |
26/03/2009 | 10:23 | Dow Jones News | UPDATE: Roche Effectively Seals $46.8 Billion Genentech Takeover | NYSE:DNA | Genentech Inc. |
26/03/2009 | 08:05 | Dow Jones News | Roche Completes Genentech Takeover, Holds 93.2% | NYSE:DNA | Genentech Inc. |
26/03/2009 | 07:37 | Dow Jones News | Roche Completes Tender Offer For Genentech, Holds 93.2% | NYSE:DNA | Genentech Inc. |
25/03/2009 | 13:44 | Dow Jones News | 2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan | NYSE:DNA | Genentech Inc. |
25/03/2009 | 11:43 | Dow Jones News | UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGM | NYSE:DNA | Genentech Inc. |
24/03/2009 | 19:08 | Dow Jones News | Roche Says RiskMetrics Backs Genentech Takeover At $95/Share | NYSE:DNA | Genentech Inc. |
19/03/2009 | 18:09 | Dow Jones News | EU Panel Backs Novartis' Glivec In Kit-positive GIST | NYSE:DNA | Genentech Inc. |
18/03/2009 | 14:55 | Dow Jones News | Roche Shares Down On Actemra; Herceptin Success Of Little Help | NYSE:DNA | Genentech Inc. |
18/03/2009 | 08:16 | Dow Jones News | Roche's Herceptin Extends Life In Aggressive Stomach Cancer | NYSE:DNA | Genentech Inc. |
18/03/2009 | 07:33 | Dow Jones News | Roche: Herceptin Prolongs Life In Stomach Cancer | NYSE:DNA | Genentech Inc. |
18/03/2009 | 05:32 | Dow Jones News | UPDATE: Chugai,Roche Face Arthritis Drug Side Effect Setback | NYSE:DNA | Genentech Inc. |
18/03/2009 | 02:05 | Dow Jones News | Chugai:Undeniable Actemra Side Effects Tied To Patient Deaths | NYSE:DNA | Genentech Inc. |
17/03/2009 | 23:54 | Dow Jones News | Biotechnology Group Praises Biologic Drugs Bill | NYSE:DNA | Genentech Inc. |
17/03/2009 | 21:29 | Dow Jones News | 5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering Tuesday | NYSE:DNA | Genentech Inc. |
17/03/2009 | 20:25 | Dow Jones News | 4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering Tuesday | NYSE:DNA | Genentech Inc. |
17/03/2009 | 18:53 | Dow Jones News | 3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing Tuesday | NYSE:DNA | Genentech Inc. |
17/03/2009 | 18:01 | Dow Jones News | 2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing Tuesday | NYSE:DNA | Genentech Inc. |
17/03/2009 | 17:13 | Dow Jones News | UPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing Tuesday | NYSE:DNA | Genentech Inc. |
16/03/2009 | 21:57 | Dow Jones News | MARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&A | NYSE:DNA | Genentech Inc. |
16/03/2009 | 19:49 | Dow Jones News | MARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&A | NYSE:DNA | Genentech Inc. |
16/03/2009 | 07:37 | Dow Jones News | Roche Acquires Innovatis AG For EUR15 Million | NYSE:DNA | Genentech Inc. |
13/03/2009 | 13:45 | Dow Jones News | Genentech-Roche Deal Shows Attraction Of Biotech Assets | NYSE:DNA | Genentech Inc. |
12/03/2009 | 20:15 | Dow Jones News | US Antitrust Review May Not Pose Threat To Drug Co Mergers | NYSE:DNA | Genentech Inc. |
12/03/2009 | 15:06 | Dow Jones News | UPDATE: Gilead To Buy CV Therapeutics For $1.4 Billion | NYSE:DNA | Genentech Inc. |
12/03/2009 | 12:10 | Dow Jones News | 4th UPDATE: Roche Seals $46.8 Billion Genentech Deal | NYSE:DNA | Genentech Inc. |
12/03/2009 | 09:32 | Dow Jones News | 3rd UPDATE: Roche Seals $46.8 Billion Genentech Deal | NYSE:DNA | Genentech Inc. |
12/03/2009 | 08:49 | Dow Jones News | Roche Chairman: Friendly Deal With Genentech Cuts Out Uncertainty | NYSE:DNA | Genentech Inc. |